CG Oncology, Inc. (CGON)
CG Oncology Market Cap : 5.333B for May 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.829B |
| Gilead Sciences, Inc. | 161.98B |
| Neurocrine Biosciences, Inc. | 15.64B |
| XOMA Royalty Corp. | 524.84M |
| Puma Biotechnology, Inc. | 359.60M |
Market Cap Related Metrics
| PS Ratio | 1010.62 |
| PEG Ratio | -0.4521 |
| Price to Book Value | 4.885 |
| Price | 64.55 |
| Earnings Yield | -3.63% |
| PEGY Ratio | -0.4521 |